FDA must make home medical devices accessible to blind users
H.R. 5605 — Medical Device Nonvisual Accessibility Act of 2025 · Filed by Jan Schakowsky (D-IL) · 26 cosponsors · Introduced Sep 26, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires medical device manufacturers to make home-use devices with digital interfaces accessible to blind and low-vision users—meaning the devices must work equally well without sight as with sight. The FDA gets 1 year to write rules and 2 years to finalize them; manufacturers then have 1 year to comply. Devices can be exempted only if accessibility would fundamentally alter the product or impose undue hardship on the maker.
Why we flagged it
The bill's core mechanism is a civil-rights accessibility mandate for medical devices, grounded in the Rehabilitation Act framework and designed to ensure equal access for blind and low-vision users. It is not a market intervention, subsidy, or deregulation—it is a functional-access requirement.
What the text implies
- Manufacturers may face upfront design costs, but the bill allows 3 years (1 year for rules + 2 years for finalization + 1 year for compliance) to plan and implement, reducing surprise compliance burden.
- The waiver standard ('clear and convincing evidence' of fundamental alteration or undue hardship) is high, meaning most manufacturers will be expected to comply; waivers are not a loophole.
- Devices cleared/approved BEFORE the effective date are grandfathered—only new devices must comply, limiting retrofit costs.
- The bill requires FDA consultation with the Architectural and Transportation Barriers Compliance Board and blind/low-vision individuals, embedding disability expertise into standard-setting and reducing risk of impractical rules.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Blind and low-vision citizens gain independent, private, and safe access to home medical devices (blood pressure monitors, sleep apnea machines, chemotherapy devices) that are currently inaccessible to them. The bill imposes a design standard on manufacturers but includes a waiver for genuine hardship, balancing accessibility rights against feasibility.
Named in the bill
FDA (Food and Drug Administration), Architectural and Transportation Barriers Compliance Board, Medical device manufacturers, Blind and low-vision consumers
Where it stands
26 cosponsors: 22 Democrats, 4 Republicans.
- Sep 26, 2025 — Introduced · Congress.gov: “Introduced in House”
- Sep 26, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 2 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $20,000 in lobbying spend. A filing names 12 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Jan Schakowsky, the sponsor, reported $88,051 in PAC receipts in the 2026 cycle.
- National Federation of the Blind — $20,000 on 2 filings
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (6,003 characters) on Jun 3, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Dec 2025 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“FDA must make home medical devices accessible to blind users” QuorumCivic. https://share.quorumcivic.app/bill/119/hr5605 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.